Literature DB >> 18287330

VE-cadherin and beta-catenin binding dynamics during histamine-induced endothelial hyperpermeability.

Mingzhang Guo1, Jerome W Breslin, Mack H Wu, Cara J Gottardi, Sarah Y Yuan.   

Abstract

Beta-catenin plays an important role in the regulation of vascular endothelial cell-cell adhesions and barrier function by linking the VE-cadherin junction complex to the cytoskeleton. The purpose of this study was to evaluate the effect of beta-catenin and VE-cadherin interactions on endothelial permeability during inflammatory stimulation by histamine. We first assessed the ability of a beta-catenin binding polypeptide known as inhibitor of beta-catenin and T cell factor (ICAT) to compete beta-catenin binding to VE-cadherin in vitro. We then overexpressed recombinant FLAG-ICAT in human umbilical vein endothelial cells (HUVECs) to study its impact on endothelial barrier function controlled by cell-cell adhesions. The binding of beta-catenin to VE-cadherin was quantified before and after stimulation with histamine along with measurements of transendothelial electrical resistance (TER) and apparent permeability to albumin (P(a)) under the same conditions. The results showed that ICAT bound to beta-catenin and competitively inhibited binding of the VE-cadherin cytoplasmic domain to beta-catenin in a concentration-dependent manner. Overexpression of FLAG-ICAT in endothelial cell monolayers did not affect their basal permeability properties, as indicated by unaltered TER and P(a); however, the magnitude and duration of histamine-induced decreases in TER were significantly augmented. Likewise, the increase in P(a) in the presence of histamine was exacerbated. Overexpression of FLAG-ICAT also significantly decreased the level of beta-catenin-associated VE-cadherin following histamine stimulation. Taken together, these data suggest that inflammatory agents like histamine cause a transient and reversible disruption of binding between beta-catenin and VE-cadherin, during which endothelial permeability is elevated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18287330      PMCID: PMC4128490          DOI: 10.1152/ajpcell.90607.2007

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  50 in total

1.  Inflammatory mediators induce sequestration of VE-cadherin in cultured human endothelial cells.

Authors:  J S Alexander; B C Alexander; L A Eppihimer; N Goodyear; R Haque; C P Davis; T J Kalogeris; D L Carden; Y N Zhu; C G Kevil
Journal:  Inflammation       Date:  2000-04       Impact factor: 4.092

Review 2.  Signal transduction pathways in enhanced microvascular permeability.

Authors:  S Y Yuan
Journal:  Microcirculation       Date:  2000-12       Impact factor: 2.628

3.  Regulation of E-cadherin/Catenin association by tyrosine phosphorylation.

Authors:  S Roura; S Miravet; J Piedra; A García de Herreros; M Duñach
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

4.  Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeability.

Authors:  M Corada; F Liao; M Lindgren; M G Lampugnani; F Breviario; R Frank; W A Muller; D J Hicklin; P Bohlen; E Dejana
Journal:  Blood       Date:  2001-03-15       Impact factor: 22.113

5.  Histamine stimulates phosphorylation of adherens junction proteins and alters their link to vimentin.

Authors:  D Michael Shasby; Dana R Ries; Sandra S Shasby; Michael C Winter
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-06       Impact factor: 5.464

6.  Crystal structure of a beta-catenin/Tcf complex.

Authors:  T A Graham; C Weaver; F Mao; D Kimelman; W Xu
Journal:  Cell       Date:  2000-12-08       Impact factor: 41.582

7.  Histamine alters endothelial barrier function at cell-cell and cell-matrix sites.

Authors:  A B Moy; M Winter; A Kamath; K Blackwell; G Reyes; I Giaever; C Keese; D M Shasby
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-05       Impact factor: 5.464

8.  Reversibility of increased microvessel permeability in response to VE-cadherin disassembly.

Authors:  X Gao; P Kouklis; N Xu; R D Minshall; R Sandoval; S M Vogel; A B Malik
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-12       Impact factor: 5.464

9.  The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin.

Authors:  A H Huber; W I Weis
Journal:  Cell       Date:  2001-05-04       Impact factor: 41.582

10.  Myosin light chain phosphorylation in neutrophil-stimulated coronary microvascular leakage.

Authors:  Sarah Y Yuan; Mack H Wu; Elena E Ustinova; Mingzhang Guo; John H Tinsley; Primal De Lanerolle; Wenjuan Xu
Journal:  Circ Res       Date:  2002-06-14       Impact factor: 17.367

View more
  30 in total

1.  Interleukin-1β-induced barrier dysfunction is signaled through PKC-θ in human brain microvascular endothelium.

Authors:  Robert R Rigor; Richard S Beard; Olesya P Litovka; Sarah Y Yuan
Journal:  Am J Physiol Cell Physiol       Date:  2012-03-07       Impact factor: 4.249

Review 2.  Molecular mechanisms of endothelial hyperpermeability: implications in inflammation.

Authors:  Puneet Kumar; Qiang Shen; Christopher D Pivetti; Eugene S Lee; Mack H Wu; Sarah Y Yuan
Journal:  Expert Rev Mol Med       Date:  2009-06-30       Impact factor: 5.600

3.  Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/β-catenin signaling.

Authors:  Shibani Pati; Aarif Y Khakoo; Jing Zhao; Fernando Jimenez; Michael H Gerber; Matthew Harting; John B Redell; Raymond Grill; Yoichi Matsuo; Sushovan Guha; Charles S Cox; Marvin S Reitz; John B Holcomb; Pramod K Dash
Journal:  Stem Cells Dev       Date:  2010-10-18       Impact factor: 3.272

4.  Monocytic adhesion molecule expression and monocyte-endothelial cell dysfunction are increased in patients with peripheral vascular disease versus patients with abdominal aortic aneurysms.

Authors:  Eugene S Lee; Elyse N Van Spyk; Kevin C Chun; Robert L Pitts; Mack H Wu; Sarah Y Yuan
Journal:  J Surg Res       Date:  2012-07-07       Impact factor: 2.192

5.  Involvement of the H1 Histamine Receptor, p38 MAP Kinase, Myosin Light Chains Kinase, and Rho/ROCK in Histamine-Induced Endothelial Barrier Dysfunction.

Authors:  Shaquria P Adderley; Xun E Zhang; Jerome W Breslin
Journal:  Microcirculation       Date:  2015-05       Impact factor: 2.628

Review 6.  Relationship between G proteins coupled receptors and tight junctions.

Authors:  Lorenza González-Mariscal; Arturo Raya-Sandino; Laura González-González; Christian Hernández-Guzmán
Journal:  Tissue Barriers       Date:  2018-02-08

7.  Histamine activates p38 MAP kinase and alters local lamellipodia dynamics, reducing endothelial barrier integrity and eliciting central movement of actin fibers.

Authors:  Shaquria P Adderley; Curtis Lawrence; Eyong Madonia; Joseph O Olubadewo; Jerome W Breslin
Journal:  Am J Physiol Cell Physiol       Date:  2015-05-06       Impact factor: 4.249

8.  Ezrin, radixin, and moesin are phosphorylated in response to 2-methoxyestradiol and modulate endothelial hyperpermeability.

Authors:  Natalia V Bogatcheva; Marina A Zemskova; Boris A Gorshkov; Kyung Mi Kim; Gregory A Daglis; Christophe Poirier; Alexander D Verin
Journal:  Am J Respir Cell Mol Biol       Date:  2011-06-09       Impact factor: 6.914

9.  A disintegrin and metalloproteinase 15 contributes to atherosclerosis by mediating endothelial barrier dysfunction via Src family kinase activity.

Authors:  Chongxiu Sun; Mack H Wu; Eugene S Lee; Sarah Y Yuan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-08-16       Impact factor: 8.311

10.  TNF-induced activation of pulmonary microvessel endothelial cells: a role for GSK3beta.

Authors:  Arnold Johnson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-02-13       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.